Recombinant Horse NGF Protein, N-His

Nerve Growth Factor (NGF) is a pivotal neurotrophic factor primarily involved in the growth, maintenance, and survival of neurons. Its discovery in the 1950s marked a significant advancement in neurobiology, leading to an enhanced understanding of neuronal development and the mechanisms underlying neurodegenerative diseases. NGF is not only crucial for the development of sensory and sympathetic neurons but also plays a role in modulating pain perception and inflammatory responses. The recombinant production of NGF has enabled researchers to explore its therapeutic potential in various neurological conditions, such as Alzheimer's disease, neuropathic pain, and spinal cord injuries. Advances in molecular biology techniques have facilitated the synthesis of NGF in engineered systems, ensuring a reliable supply for both basic research and clinical applications. Moreover, studies on NGF’s receptor interactions and signaling pathways have unveiled its complex role in neuroprotection and neuroinflammation. Current research focuses on optimizing NGF formulations to enhance stability and efficacy, aiming to translate these findings into effective therapies for neurodegenerative disorders. Consequently, recombinant NGF protein serves as a valuable tool in both fundamental research and therapeutic interventions, representing a promising avenue for improving neuronal health and addressing the challenges of neurodegenerative diseases.